SST-215

N/A

Report date: 2025/01/26 19:04:19
NME

Base Information

Drug NameSST-215
Drug Alias NameWnt inhibitors (StemSynergy Therapeutics)SST-215
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionWingless type MMTV integration site family protein inhibitors
TargetsWingless type MMTV integration site family protein
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesStemSynergy Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesStemSynergy Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell LungColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A